Udayan Guha

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

Anish Thomas, Arun Rajan, Arlene Berman et al. · The Lancet Oncology · 2015 · 299 citations · Full text

Medicine, Oncology, Pharmacology +8

Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial

Ariel López-Chávez, Anish Thomas, Arun Rajan et al. · Journal of Clinical Oncology · 2015 · 235 citations

Medicine, Molecular Medicine, Oncology +17

Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins

Marianne S. Poruchynsky, Edina Komlódi-Pásztor, Shana Y. Trostel et al. · Proceedings of the National Academy of Sciences · 2015 · 182 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer

Nitin Roper, Anna‐Leigh Brown, Jun S. Wei et al. · Cell Reports Medicine · 2020 · 181 citations · Full text

Medicine, Genetics, Oncology +17

Identification of <i>KIF5B-RET</i> and <i>GOPC-ROS1</i> Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions

Yoshiyuki Suehara, Maria E. Arcila, Lu Wang et al. · Clinical Cancer Research · 2012 · 178 citations

Medicine, Molecular Biology, Oncology +17